Literature DB >> 10762045

The solid phase synthesis of tetrahydroisoquinolines having cdc25B inhibitory activity.

E L Fritzen1, A S Brightwell, L A Erickson, D L Romero.   

Abstract

A solid phase synthesis of substituted tetrahydroisoquinolines was developed and used to prepare directed libraries of compounds for screening against the protein phosphatase, CDC25B. From these libraries, a compound was found having approximately a 4-fold improvement in activity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10762045     DOI: 10.1016/s0960-894x(00)00069-x

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  1 in total

Review 1.  Is Cdc25 a druggable target?

Authors:  John S Lazo; Peter Wipf
Journal:  Anticancer Agents Med Chem       Date:  2008-12       Impact factor: 2.505

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.